ID

26193

Description

Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00167648

Link

https://clinicaltrials.gov/show/NCT00167648

Keywords

Versions (1)
  1. 10/11/17 10/11/17 -
Copyright Holder

see clinicaltrials.gov

Uploaded on

October 11, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Cancer NCT00167648

English

Eligibility Cancer NCT00167648

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00167648
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. men 18 years or older with a histologic diagnosis of low to intermediate risk prostate cancer prior to radical prostatectomy as defined by:
Description

Age and histologic diagnosis to intermediate risk prostate cancer prior to radical prostatectomy

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0033578
UMLS CUI [2,2]
C0344441
UMLS CUI [2,3]
C0035648
UMLS CUI [3,1]
C0332152
UMLS CUI [3,2]
C0194810
1. clinical stage t1-t2b
Description

Clinical Stage

Data type

boolean

Alias
UMLS CUI [1]
C1300072
2. psa < 20
Description

PSA measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201544
3. gleason score < 7
Description

Gleason score

Data type

boolean

Alias
UMLS CUI [1]
C0332326
patients who have more than one of the following prognostic factors: t2b, gleason 7, psa 10-20 are not eligible.
Description

Prognostic Factors

Data type

boolean

Alias
UMLS CUI [1,1]
C1514474
UMLS CUI [1,2]
C1300072
UMLS CUI [2,1]
C1514474
UMLS CUI [2,2]
C0332326
UMLS CUI [3,1]
C1514474
UMLS CUI [3,2]
C0138741
2. patient's tumor must be considered surgically resectable as determined by a urologic evaluation
Description

Surgically resectable as determined by a urologic evaluation

Data type

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C0031809
UMLS CUI [1,3]
C0042077
3. ecog performance status of 0-1
Description

Ecog performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
4. life expectancy greater than 2 years
Description

Life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
5. able to understand and give informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
6. patients must agree not to take dietary phytoestrogens or other estrogen containing supplements
Description

Compliance behavior concomitant medications

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2347852
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with locally advanced or high-risk disease as defined above.
Description

Locally adcanced or high-risk disease

Data type

boolean

Alias
UMLS CUI [1]
C0677984
UMLS CUI [2]
C0475283
2. patients who have a testosterone less than 280 ng/dl.
Description

Testosterone Measurement

Data type

boolean

Alias
UMLS CUI [1]
C0523912
3. patients who have evidence of cerebrovascular accident or ischemia, recent deep venous thrombosis, pulmonary emboli, unstable angina or clinical congestive heart failure.
Description

Comorbidities

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0038454
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0917798
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C0332185
UMLS CUI [3,3]
C0149871
UMLS CUI [4,1]
C0009488
UMLS CUI [4,2]
C0034065
UMLS CUI [5,1]
C0009488
UMLS CUI [5,2]
C0002965
UMLS CUI [6,1]
C0009488
UMLS CUI [6,2]
C0018802
4. patients who are receiving any other investigational therapy.
Description

Investigational therapy

Data type

boolean

Alias
UMLS CUI [1]
C2348568
5. patients with an active serious infection or other serious underlying medical condition that would otherwise impair their ability to receive protocol treatment.
Description

Active serious Infection and Comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205404
6. dementia or significantly altered mental status that would prohibit the understanding and/or giving of informed consent.
Description

Limited ability to give informed consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
7. patients with immunodeficiency or on oral corticosteroids
Description

Immunodeficiency or oral corticosteroids

Data type

boolean

Alias
UMLS CUI [1]
C0021051
UMLS CUI [2]
C0239126
8. histologic evidence of small cell carcinoma of the prostate.
Description

Histologic evidence of small cell carcinoma of the prostate

Data type

boolean

Alias
UMLS CUI [1,1]
C0262584
UMLS CUI [1,2]
C0033572
UMLS CUI [1,3]
C0344441
9. patients with a prior history of myocardial infarction, pulmonary embolism, cva or atrial fibrillation.
Description

Patients with a prior history of myocardial infarction, pulmonary embolism, cva or atrial fibrillation

Data type

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0027051
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0034065
UMLS CUI [3,1]
C0262926
UMLS CUI [3,2]
C0038454
UMLS CUI [4,1]
C0262926
UMLS CUI [4,2]
C0004238
10. patients with active thrombophlebitis.
Description

Patients with active thrombophlebitis

Data type

boolean

Alias
UMLS CUI [1]
C0040046
11. patients with evidence of active angina as evidenced by chest pain responsive to nitroglycerin or other anginal equivalent.
Description

Vasidilator responsive angina pectoris

Data type

boolean

Alias
UMLS CUI [1,1]
C0002962
UMLS CUI [1,2]
C0205342
UMLS CUI [1,3]
C0042402
12. medical conditions, which, in the opinion of the investigators would jeopardize either the patient or the integrity of the data obtained
Description

medical conditions, which, in the opinion of the investigators would jeopardize either the patient or the integrity of the data obtained

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1113679
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0242568
13. patients who are currently receiving active therapy for other neoplastic disorders will not be eligible for study.
Description

Active therpy for other neoplastic disorders

Data type

boolean

Alias
UMLS CUI [1,1]
C0085183
UMLS CUI [1,2]
C0597030
14. patients taking any of the following medications who cannot discontinue these medications for three weeks during administration of androgen deprivation: aprepitant, bexarotene, clarithromycin, itraconazole, ketoconazole, st. john's wort.
Description

Ongoing medication

Data type

boolean

Alias
UMLS CUI [1,1]
C2826666
UMLS CUI [1,2]
C1176306
UMLS CUI [2,1]
C2826666
UMLS CUI [2,2]
C0765273
UMLS CUI [3,1]
C2826666
UMLS CUI [3,2]
C0055856
UMLS CUI [4,1]
C2826666
UMLS CUI [4,2]
C0064113
UMLS CUI [5,1]
C2826666
UMLS CUI [5,2]
C0022625
UMLS CUI [6,1]
C2826666
UMLS CUI [6,2]
C0936242
Back to the top of the page

Similar models

Eligibility Cancer NCT00167648

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00167648
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age and histologic diagnosis to intermediate risk prostate cancer prior to radical prostatectomy
Item
1. men 18 years or older with a histologic diagnosis of low to intermediate risk prostate cancer prior to radical prostatectomy as defined by:
boolean
C0001779 (UMLS CUI [1])
C0033578 (UMLS CUI [2,1])
C0344441 (UMLS CUI [2,2])
C0035648 (UMLS CUI [2,3])
C0332152 (UMLS CUI [3,1])
C0194810 (UMLS CUI [3,2])
Clinical Stage
Item
1. clinical stage t1-t2b
boolean
C1300072 (UMLS CUI [1])
PSA measurement
Item
2. psa < 20
boolean
C0201544 (UMLS CUI [1])
Gleason score
Item
3. gleason score < 7
boolean
C0332326 (UMLS CUI [1])
Prognostic Factors
Item
patients who have more than one of the following prognostic factors: t2b, gleason 7, psa 10-20 are not eligible.
boolean
C1514474 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C1514474 (UMLS CUI [2,1])
C0332326 (UMLS CUI [2,2])
C1514474 (UMLS CUI [3,1])
C0138741 (UMLS CUI [3,2])
Surgically resectable as determined by a urologic evaluation
Item
2. patient's tumor must be considered surgically resectable as determined by a urologic evaluation
boolean
C0543467 (UMLS CUI [1,1])
C0031809 (UMLS CUI [1,2])
C0042077 (UMLS CUI [1,3])
Ecog performance status
Item
3. ecog performance status of 0-1
boolean
C1520224 (UMLS CUI [1])
Life expectancy
Item
4. life expectancy greater than 2 years
boolean
C0023671 (UMLS CUI [1])
Informed consent
Item
5. able to understand and give informed consent
boolean
C0021430 (UMLS CUI [1])
Compliance behavior concomitant medications
Item
6. patients must agree not to take dietary phytoestrogens or other estrogen containing supplements
boolean
C1321605 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Locally adcanced or high-risk disease
Item
1. patients with locally advanced or high-risk disease as defined above.
boolean
C0677984 (UMLS CUI [1])
C0475283 (UMLS CUI [2])
Testosterone Measurement
Item
2. patients who have a testosterone less than 280 ng/dl.
boolean
C0523912 (UMLS CUI [1])
Comorbidities
Item
3. patients who have evidence of cerebrovascular accident or ischemia, recent deep venous thrombosis, pulmonary emboli, unstable angina or clinical congestive heart failure.
boolean
C0009488 (UMLS CUI [1,1])
C0038454 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0917798 (UMLS CUI [2,2])
C0009488 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
C0149871 (UMLS CUI [3,3])
C0009488 (UMLS CUI [4,1])
C0034065 (UMLS CUI [4,2])
C0009488 (UMLS CUI [5,1])
C0002965 (UMLS CUI [5,2])
C0009488 (UMLS CUI [6,1])
C0018802 (UMLS CUI [6,2])
Investigational therapy
Item
4. patients who are receiving any other investigational therapy.
boolean
C2348568 (UMLS CUI [1])
Active serious Infection and Comorbidity
Item
5. patients with an active serious infection or other serious underlying medical condition that would otherwise impair their ability to receive protocol treatment.
boolean
C0009450 (UMLS CUI [1])
C0009488 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Limited ability to give informed consent
Item
6. dementia or significantly altered mental status that would prohibit the understanding and/or giving of informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Immunodeficiency or oral corticosteroids
Item
7. patients with immunodeficiency or on oral corticosteroids
boolean
C0021051 (UMLS CUI [1])
C0239126 (UMLS CUI [2])
Histologic evidence of small cell carcinoma of the prostate
Item
8. histologic evidence of small cell carcinoma of the prostate.
boolean
C0262584 (UMLS CUI [1,1])
C0033572 (UMLS CUI [1,2])
C0344441 (UMLS CUI [1,3])
Patients with a prior history of myocardial infarction, pulmonary embolism, cva or atrial fibrillation
Item
9. patients with a prior history of myocardial infarction, pulmonary embolism, cva or atrial fibrillation.
boolean
C0262926 (UMLS CUI [1,1])
C0027051 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0034065 (UMLS CUI [2,2])
C0262926 (UMLS CUI [3,1])
C0038454 (UMLS CUI [3,2])
C0262926 (UMLS CUI [4,1])
C0004238 (UMLS CUI [4,2])
Patients with active thrombophlebitis
Item
10. patients with active thrombophlebitis.
boolean
C0040046 (UMLS CUI [1])
Vasidilator responsive angina pectoris
Item
11. patients with evidence of active angina as evidenced by chest pain responsive to nitroglycerin or other anginal equivalent.
boolean
C0002962 (UMLS CUI [1,1])
C0205342 (UMLS CUI [1,2])
C0042402 (UMLS CUI [1,3])
medical conditions, which, in the opinion of the investigators would jeopardize either the patient or the integrity of the data obtained
Item
12. medical conditions, which, in the opinion of the investigators would jeopardize either the patient or the integrity of the data obtained
boolean
C0009488 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0242568 (UMLS CUI [2,2])
Active therpy for other neoplastic disorders
Item
13. patients who are currently receiving active therapy for other neoplastic disorders will not be eligible for study.
boolean
C0085183 (UMLS CUI [1,1])
C0597030 (UMLS CUI [1,2])
Ongoing medication
Item
14. patients taking any of the following medications who cannot discontinue these medications for three weeks during administration of androgen deprivation: aprepitant, bexarotene, clarithromycin, itraconazole, ketoconazole, st. john's wort.
boolean
C2826666 (UMLS CUI [1,1])
C1176306 (UMLS CUI [1,2])
C2826666 (UMLS CUI [2,1])
C0765273 (UMLS CUI [2,2])
C2826666 (UMLS CUI [3,1])
C0055856 (UMLS CUI [3,2])
C2826666 (UMLS CUI [4,1])
C0064113 (UMLS CUI [4,2])
C2826666 (UMLS CUI [5,1])
C0022625 (UMLS CUI [5,2])
C2826666 (UMLS CUI [6,1])
C0936242 (UMLS CUI [6,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial